Anvisa aprova medicamento para tratamento de atrofia muscular espinhal (AME)

Imported from official source

Announcement

Safety Classified by Officially

Produto inovador é indicado para o tratamento de adultos e crianças acima de 2 anos

This is an extract. The publication continues at the source.

Read the original at the source: https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2026/anvisa-aprova-medicamento-para-tratamento-da-ame

Officially imported this from Agência Nacional de Vigilância Sanitária (Anvisa)’s own source and shows an extract. If you work there, claiming the profile and verifying the domain lets you choose to show the full text here.

Provenance

Organization
Agência Nacional de Vigilância Sanitária (Anvisa) — imported from official source
Official source
https://www.gov.br/anvisa/++api++/@search?portal_type=News%20Item&sort_on=effective&sort_order=reverse&b_size=25&metadata_fields=effective&metadata_fields=UID API
Imported
October 29, 2026 09:01
Versions
1 recorded
Identity
f495e6b1e5b743b9810897375c0cf2aa

Officially records where a publication came from, not whether it is true. Imported records are reproduced from an organization's own official source.